Basic Information
NOLVADEX TABLET 10 mg
TABLET, FILM COATED
Regulatory Information
SIN00794P
May 6, 1988
Prescription Only
Therapeutic
ORAL
August 10, 2023
May 30, 2025
XL02BA01
Company Information
Active Ingredients
TAMOXIFEN CITRATE 15.2 mg EQV TAMOXIFEN
Strength: 10 mg
Detailed Information
Contraindications
**4.3 Contraindications** **_Pregnancy:_** NOLVADEX must not be given during pregnancy. Premenopausal patients must be carefully examined before treatment to exclude the possibility of pregnancy (see also Pregnancy and lactation – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_). NOLVADEX should not be given to patients who have experienced hypersensitivity to the product or any of its ingredients.
Indication Information
**4.1 Therapeutic indication** NOLVADEX is indicated for the treatment of breast cancer.